In this observational cohort study, we used the Maccabi Healthcare Services (MHS) database, Israel's second-largest healthcare maintenance organization (HMO), to compare kidney outcomes in patients with type 2 diabetes initiating GLP-1 RAs versus basal insulin. Here, GLP1R is linked to type 2 diabetes mellitus.